iNod™ Ultrasound-Guided Needle Biopsy System Study
← catalyst calendarSponsored by Boston Scientific Corporation (industry) · BSX — their whole pipeline →.
Phase
Not applicable
Status
Withdrawn
Study type
Interventional
Design
Na · None · Diagnostic
Enrollment
0actual
Every value on this page is a field the sponsor filed with ClinicalTrials.gov, reproduced. Dates are their own estimates, revised as a study runs, unless the registry marks them actual. sources →
Source: ClinicalTrials.gov, retrieved 2026-08-19
Why the sponsor stopped it
Sponsor decision
As filed on the registry record, in the sponsor's own words.
Dates
each axis at the precision it was filed, with the registry's own basis| Date | Filed | Basis | What it is |
|---|---|---|---|
| Start | Jan 2025 | estimated | When the study began enrolling |
| Primary completion | Feb 2026 | estimated | The date the last participant is measured for the primary outcome — the readout window |
| Study completion | Feb 2027 | estimated | The whole study's end, after follow-up |
| First posted | 2023-04-07 | actual | When this record first appeared on the registry |
| Results posted | — | When the sponsor posted results to the registry | |
| Record updated | 2024-03-08 | actual | The sponsor's own last edit to this record — every projection above is as current as this date |
What it studies
Conditions
- Solitary Pulmonary Nodule
- Multiple Pulmonary Nodules
- Biopsy, Fine-Needle
Intervention
- Device: iNod™ System — also filed as iNod™ Ultrasound Imaging System, iNod™ SUD
Primary outcomes
what the primary-completion date above is the date OFProportion of patients where the needle is visualized by the iNOD system inside the lesion
measured Procedure
Adverse Events
measured Procedure
Permalink · BSX's whole pipeline · Catalyst calendar · Every registered study · What changed